Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Trial to Assess the Tolerability of AVANZ® Cupressus Immunotherapy

NCT02069535 is registered in ClinicalTrials.gov with ALK-Abelló A/S as lead sponsor.

NCT NCT02069535
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02069535 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Trial to Assess the Tolerability of AVANZ® Cupressus Immunotherapy
Lead sponsor
ALK-Abelló A/S
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2014
Completion date
November 30, 2014
Enrollment
52 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allergic rhinoconjunctivitis